Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View


Invitae (NVTA) has entered into a definitive agreement to acquire Ciitizen, a consumer health tech company. Under the agreement, Invitae will acquire Ciitizen for approximately $325 million, consisting of approximately $125 million in cash and approximately 7.07 million shares of Invitae common stock.


RTTNews | Sep 7, 2021 08:23AM EDT

08:23 Tuesday, September 7, 2021 (RTTNews.com) - Invitae (NVTA) has entered into a definitive agreement to acquire Ciitizen, a consumer health tech company. Under the agreement, Invitae will acquire Ciitizen for approximately $325 million, consisting of approximately $125 million in cash and approximately 7.07 million shares of Invitae common stock.

Ciitizen enables patients to collect, store and share their medical records in a single location. Ciitizen developed machine learning and AI technologies to abstract critical information from unstructured health records to advance the understanding of diseases.

Invitae said the acquisition would enhance its platform by providing patients an easy-to-use, centralized hub for their genomic and clinical information.

Read the original article on RTTNews ( https://www.rttnews.com/3223715/invitae-to-acquire-ciitizen-quick-facts.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC